{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:53:51Z","timestamp":1773417231156,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-026-01490-1","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T01:10:13Z","timestamp":1773364213000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expanding the Autosomal Recessive Hypophosphatemic Rickets Type I Carrier Phenotype and Adult Treatment with Burosumab"],"prefix":"10.1007","volume":"117","author":[{"given":"Noor Alhuda","family":"Sawalha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos Loreto","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dora","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry","family":"Siminoski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda","family":"Bonewald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1557-9185","authenticated-orcid":false,"given":"Leanne M.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"11","key":"1490_CR1","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/ng1905","volume":"38","author":"JQ Feng","year":"2006","unstructured":"Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, Yuan B, Yu X et al (2006) Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 38(11):1310\u20131315. https:\/\/doi.org\/10.1038\/ng1905","journal-title":"Nat Genet"},{"issue":"5","key":"1490_CR2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1136\/adc.51.5.360","volume":"51","author":"TC Stamp","year":"1976","unstructured":"Stamp TC, Baker LR (1976) Recessive hypophosphataemic rickets, and possible aetiology of the \u201cvitamin D-resistant\u201d syndrome. Arch Dis Child 51(5):360\u2013365. https:\/\/doi.org\/10.1136\/adc.51.5.360","journal-title":"Arch Dis Child"},{"issue":"11","key":"1490_CR3","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/ng1868","volume":"38","author":"B Lorenz-Depiereux","year":"2006","unstructured":"Lorenz-Depiereux B, Bastepe M, Benet-Pag\u00e8s A, Amyere M, Wagenstaller J, M\u00fcller-Barth U, Badenhoop K et al (2006) DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet 38(11):1248\u20131250. https:\/\/doi.org\/10.1038\/ng1868","journal-title":"Nat Genet"},{"issue":"10","key":"1490_CR4","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1210\/clinem\/dgac433","volume":"107","author":"X Bai","year":"2022","unstructured":"Bai X, Levental M, Karaplis AC (2022) Burosumab treatment for autosomal recessive hypophosphatemic rickets type 1 (ARHR1). J Clin Endocrinol Metab 107(10):2777\u20132783. https:\/\/doi.org\/10.1210\/clinem\/dgac433","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1490_CR5","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s00223-020-00755-7","volume":"107","author":"X Ni","year":"2020","unstructured":"Ni X, Li X, Zhang Q, Liu C, Gong Y, Wang O, Li M et al (2020) Clinical characteristics and bone features of autosomal recessive hypophosphatemic rickets type 1 in three Chinese families: report of five Chinese cases and review of the literature. Calcif Tissue Int 107(6):636\u2013648. https:\/\/doi.org\/10.1007\/s00223-020-00755-7","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"1490_CR6","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3892\/ijmm.2018.3730","volume":"42","author":"J Gu","year":"2018","unstructured":"Gu J, Wang C, Zhang H, Yue H, Hu W, He J, Fu W et al (2018) Targeted resequencing of phosphorus metabolism-related genes in 86 patients with hypophosphatemic rickets\/osteomalacia. Int J Mol Med 42(3):1603\u20131614. https:\/\/doi.org\/10.3892\/ijmm.2018.3730","journal-title":"Int J Mol Med"},{"key":"1490_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bone.2014.08.014","volume":"68","author":"MH Gannag\u00e9-Yared","year":"2014","unstructured":"Gannag\u00e9-Yared MH, Makrythanasis P, Chouery E, Sobacchi C, Mehawej C, Santoni FA, Guipponi M et al (2014) Exome sequencing reveals a mutation in DMP1 in a family with familial sclerosing bone dysplasia. Bone 68:142\u2013145. https:\/\/doi.org\/10.1016\/j.bone.2014.08.014","journal-title":"Bone"},{"issue":"7","key":"1490_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/jhg.2012.56","volume":"57","author":"SS Beck-Nielsen","year":"2012","unstructured":"Beck-Nielsen SS, Brixen K, Gram J, Brusgaard K (2012) Mutational analysis of PHEX, FGF23, DMP1, SLC34A3 and CLCN5 in patients with hypophosphatemic rickets. J Hum Genet 57(7):453\u2013458. https:\/\/doi.org\/10.1038\/jhg.2012.56","journal-title":"J Hum Genet"},{"issue":"12","key":"1490_CR9","doi-asserted-by":"publisher","first-page":"5906","DOI":"10.1210\/en.2012-1551","volume":"153","author":"AC Karaplis","year":"2012","unstructured":"Karaplis AC, Bai X, Falet JP, Macica CM (2012) Mineralizing enthesopathy is a common feature of renal phosphate-wasting disorders attributed to FGF23 and is exacerbated by standard therapy in hyp mice. Endocrinology 153(12):5906\u20135917. https:\/\/doi.org\/10.1210\/en.2012-1551","journal-title":"Endocrinology"},{"issue":"10","key":"1490_CR10","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1002\/jbmr.105","volume":"25","author":"O M\u00e4kitie","year":"2010","unstructured":"M\u00e4kitie O, Pereira RC, Kaitila I, Turan S, Bastepe M, Laine T, Kr\u00f6ger H et al (2010) Long-term clinical outcome and carrier phenotype in autosomal recessive hypophosphatemia caused by a novel DMP1 mutation. J Bone Miner Res 25(10):2165\u20132174. https:\/\/doi.org\/10.1002\/jbmr.105","journal-title":"J Bone Miner Res"},{"issue":"5","key":"1490_CR11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00774-010-0169-0","volume":"28","author":"R Koshida","year":"2010","unstructured":"Koshida R, Yamaguchi H, Yamasaki K, Tsuchimochi W, Yonekawa T, Nakazato M (2010) A novel nonsense mutation in the DMP1 gene in a Japanese family with autosomal recessive hypophosphatemic rickets. J Bone Miner Metab 28(5):585\u2013590. https:\/\/doi.org\/10.1007\/s00774-010-0169-0","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"1490_CR12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.bone.2009.09.016","volume":"46","author":"S Turan","year":"2010","unstructured":"Turan S, Aydin C, Bereket A, Akcay T, G\u00fcran T, Yaralioglu BA, Bastepe M, J\u00fcppner H (2010) Identification of a novel dentin matrix protein-1 (DMP-1) mutation and dental anomalies in a kindred with autosomal recessive hypophosphatemia. Bone 46(2):402\u2013409. https:\/\/doi.org\/10.1016\/j.bone.2009.09.016","journal-title":"Bone"},{"issue":"2","key":"1490_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.bone.2008.10.040","volume":"44","author":"EG Farrow","year":"2009","unstructured":"Farrow EG, Davis SI, Ward LM, Summers LJ, Bubbear JS, Keen R, Stamp TC et al (2009) Molecular analysis of DMP1 mutants causing autosomal recessive hypophosphatemic rickets. Bone 44(2):287\u2013294. https:\/\/doi.org\/10.1016\/j.bone.2008.10.040","journal-title":"Bone"},{"key":"1490_CR14","doi-asserted-by":"crossref","unstructured":"George A, Sabsay B, Simonian PA, Veis A (1993) Characterization of a novel dentin matrix acidic phosphoprotein. Implications for induction of biomineralization. J Biol Chem 268(17):12624\u201312630","DOI":"10.1016\/S0021-9258(18)31434-0"},{"issue":"2","key":"1490_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1006\/geno.1995.9867","volume":"30","author":"HM Aplin","year":"1995","unstructured":"Aplin HM, Hirst KL, Crosby AH, Dixon MJ (1995) Mapping of the human dentin matrix acidic phosphoprotein gene (DMP1) to the dentinogenesis imperfecta type II critical region at chromosome 4q21. Genomics 30(2):347\u2013349. https:\/\/doi.org\/10.1006\/geno.1995.9867","journal-title":"Genomics"},{"issue":"1","key":"1490_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22517-1","volume":"12","author":"SE Youlten","year":"2021","unstructured":"Youlten SE, Kemp JP, Logan JG, Ghirardello EJ, Sergio CM, Dack MRG, Guilfoyle SE et al (2021) Osteocyte transcriptome mapping identifies a molecular landscape controlling skeletal homeostasis and susceptibility to skeletal disease. Nat Commun 12(1):2444. https:\/\/doi.org\/10.1038\/s41467-021-22517-1","journal-title":"Nat Commun"},{"issue":"8","key":"1490_CR17","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1096\/fj.10-177816","volume":"25","author":"A Martin","year":"2011","unstructured":"Martin A, Liu S, David V, Li H, Karydis A, Feng JQ, Quarles LD (2011) Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling. FASEB J 25(8):2551\u20132562. https:\/\/doi.org\/10.1096\/fj.10-177816","journal-title":"FASEB J"},{"issue":"3","key":"1490_CR18","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1210\/en.2016-1642","volume":"158","author":"S Ichikawa","year":"2017","unstructured":"Ichikawa S, Gerard-O\u2019Riley RL, Acton D, McQueen AK, Strobel IE, Witcher PC, Feng JQ et al (2017) A mutation in the Dmp1 gene alters phosphate responsiveness in mice. Endocrinology 158(3):470\u2013476. https:\/\/doi.org\/10.1210\/en.2016-1642","journal-title":"Endocrinology"},{"issue":"11","key":"1490_CR19","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y et al (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 98(11):6500\u20136505. https:\/\/doi.org\/10.1073\/pnas.101545198","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1490_CR20","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/bcp.13763","volume":"85","author":"EA Imel","year":"2019","unstructured":"Imel EA, White KE (2019) Pharmacological management of X-linked hypophosphataemia. Br J Clin Pharmacol 85(6):1188\u20131198. https:\/\/doi.org\/10.1111\/bcp.13763","journal-title":"Br J Clin Pharmacol"},{"key":"1490_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00338","volume":"11","author":"A Schindeler","year":"2020","unstructured":"Schindeler A, Biggin A, Munns CF (2020) Clinical evidence for the benefits of burosumab therapy for X-linked hypophosphatemia (XLH) and other conditions in adults and children. Front Endocrinol 11:338. https:\/\/doi.org\/10.3389\/fendo.2020.00338","journal-title":"Front Endocrinol"},{"issue":"21","key":"1490_CR22","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","volume":"378","author":"TO Carpenter","year":"2018","unstructured":"Carpenter TO, Whyte MP, Imel EA, Boot AM, H\u00f6gler W, Linglart A, Padidela R et al (2018) Burosumab therapy in children with X-linked hypophosphatemia. N Engl J Med 378(21):1987\u20131998. https:\/\/doi.org\/10.1056\/NEJMoa1714641","journal-title":"N Engl J Med"},{"issue":"3","key":"1490_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S2213-8587(18)30338-3","volume":"7","author":"MP Whyte","year":"2019","unstructured":"Whyte MP, Carpenter TO, Gottesman GS, Mao M, Skrinar A, San Martin J, Imel EA (2019) Efficacy and safety of burosumab in children aged 1\u20134 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial. Lancet Diabetes Endocrinol 7(3):189\u2013199. https:\/\/doi.org\/10.1016\/S2213-8587(18)30338-3","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10189","key":"1490_CR24","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","volume":"393","author":"EA Imel","year":"2019","unstructured":"Imel EA, Glorieux FH, Whyte MP, Munns CF, Ward LM, Nilsson O, Simmons JH et al (2019) Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial. Lancet 393(10189):2416\u20132427. https:\/\/doi.org\/10.1016\/S0140-6736(19)30654-3","journal-title":"Lancet"},{"issue":"4","key":"1490_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1177\/0022034510363250","volume":"89","author":"A Gericke","year":"2010","unstructured":"Gericke A, Qin C, Sun Y, Redfern R, Redfern D, Fujimoto Y, Taleb H et al (2010) Different forms of DMP1 play distinct roles in mineralization. J Dent Res 89(4):355\u2013359. https:\/\/doi.org\/10.1177\/0022034510363250","journal-title":"J Dent Res"},{"issue":"2","key":"1490_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/jbmr.226","volume":"26","author":"Y Lu","year":"2011","unstructured":"Lu Y, Yuan B, Qin C, Cao Z, Xie Y, Dallas SL, McKee MD et al (2011) The biological function of DMP-1 in osteocyte maturation is mediated by its 57-kDa C-terminal fragment. J Bone Miner Res 26(2):331\u2013340. https:\/\/doi.org\/10.1002\/jbmr.226","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1490_CR27","doi-asserted-by":"publisher","first-page":"e1798","DOI":"10.1210\/clinem\/dgaa064","volume":"105","author":"A Steele","year":"2020","unstructured":"Steele A, Gonzalez R, Garbalosa JC, Steigbigel K, Grgurich T, Parisi EJ, Feinn RS et al (2020) Osteoarthritis, osteophytes, and enthesophytes affect biomechanical function in adults with X-linked hypophosphatemia. J Clin Endocrinol Metab 105(4):e1798\u2013e1814. https:\/\/doi.org\/10.1210\/clinem\/dgaa064","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1490_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jbmr.2405","volume":"30","author":"AA Khan","year":"2015","unstructured":"Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O\u2019Ryan F, Reid IR et al (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30(1):3\u201323. https:\/\/doi.org\/10.1002\/jbmr.2405","journal-title":"J Bone Miner Res"},{"issue":"2","key":"1490_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.job.2019.03.005","volume":"61","author":"S Kuroshima","year":"2019","unstructured":"Kuroshima S, Sasaki M, Sawase T (2019) Medication-related osteonecrosis of the jaw: a literature review. J Oral Biosci 61(2):99\u2013104. https:\/\/doi.org\/10.1016\/j.job.2019.03.005","journal-title":"J Oral Biosci"},{"issue":"4","key":"1490_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/0022034510397196","volume":"90","author":"A Barasch","year":"2011","unstructured":"Barasch A, Cunha-Cruz J, Curro FA, Hujoel P, Sung AH, Vena D, Voinea-Griffin AE et al (2011) Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN. J Dent Res 90(4):439\u2013444. https:\/\/doi.org\/10.1177\/0022034510397196","journal-title":"J Dent Res"},{"issue":"2","key":"1490_CR31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s002560050016","volume":"29","author":"RM Shore","year":"2000","unstructured":"Shore RM, Langman CB, Poznanski AK (2000) Lumbar and radial bone mineral density in children and adolescents with X-linked hypophosphatemia: evaluation with dual X-ray absorptiometry. Skeletal Radiol 29(2):90\u201393. https:\/\/doi.org\/10.1007\/s002560050016","journal-title":"Skeletal Radiol"},{"issue":"5","key":"1490_CR32","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s00198-017-3949-8","volume":"28","author":"GP Colares Neto","year":"2017","unstructured":"Colares Neto GP, Pereira RM, Alvarenga JC, Takayama L, Funari MF, Martin RM (2017) Evaluation of bone mineral density and microarchitectural parameters by DXA and HR-pQCT in 37 children and adults with X-linked hypophosphatemic rickets. Osteoporos Int 28(5):1685\u20131692. https:\/\/doi.org\/10.1007\/s00198-017-3949-8","journal-title":"Osteoporos Int"},{"issue":"8","key":"1490_CR33","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1007\/s00198-013-2286-9","volume":"24","author":"SS Beck-Nielsen","year":"2013","unstructured":"Beck-Nielsen SS, Brixen K, Gram J, M\u00f8lgaard C (2013) High bone mineral apparent density in children with X-linked hypophosphatemia. Osteoporos Int 24(8):2215\u20132221. https:\/\/doi.org\/10.1007\/s00198-013-2286-9","journal-title":"Osteoporos Int"},{"issue":"5","key":"1490_CR34","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1359\/jbmr.2003.18.5.807","volume":"18","author":"J Gluhak-Heinrich","year":"2003","unstructured":"Gluhak-Heinrich J, Ye L, Bonewald LF, Feng JQ, MacDougall M, Harris SE, Pavlin D (2003) Mechanical loading stimulates dentin matrix protein 1 (DMP1) expression in osteocytes in vivo. J Bone Miner Res 18(5):807\u2013817. https:\/\/doi.org\/10.1359\/jbmr.2003.18.5.807","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1490_CR35","first-page":"313","volume":"7","author":"SE Harris","year":"2007","unstructured":"Harris SE, Gluhak-Heinrich J, Harris MA, Yang W, Bonewald LF, Riha D, Rowe PS et al (2007) DMP1 and MEPE expression are elevated in osteocytes after mechanical loading in vivo: theoretical role in controlling mineral quality in the perilacunar matrix. J Musculoskelet Neuronal Interact 7(4):313\u2013315","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"10","key":"1490_CR36","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/jbmr.4101","volume":"35","author":"B Hoac","year":"2020","unstructured":"Hoac B, \u00d8stergaard M, Wittig NK, Boukpessi T, Buss DJ, Chaussain C, Birkedal H et al (2020) Genetic ablation of osteopontin in osteomalacic Hyp mice partially rescues the deficient mineralization without correcting hypophosphatemia. J Bone Miner Res 35(10):2032\u20132048. https:\/\/doi.org\/10.1002\/jbmr.4101","journal-title":"J Bone Miner Res"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01490-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-026-01490-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01490-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:04:10Z","timestamp":1773407050000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-026-01490-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1490"],"URL":"https:\/\/doi.org\/10.1007\/s00223-026-01490-1","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Noor Alhuda Sawalha received an unrestricted educational clinical training grant from Ultragenyx. Dr. Leanne Ward has participated in clinical trials with Ultragenyx, has been a consultant to Ultragenyx and Kyowa Kirin, and has been the Steering Committee Chair for the Ultragenyx XLH Disease Monitoring Program, with funds to Dr. Ward\u2019s institution. Dr. Ward has received an unrestricted educational grant from Ultragenyx to support a Fellow in Pediatric Genetic and Metabolic Bone Conditions, administered through the University of Ottawa. Dr. Rauch declares consultancy to Angitia, BioMarin, Kyowa Kirin, and Ultragenyx. All other co-authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Individuals signed informed consent regarding publishing their data and photographs.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Informed consent was obtained from individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}],"article-number":"40"}}